Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

MCA
9746
FMPP
91332
Reference Values:
An interpretive report will be provided.
Clinical References: 1. Sieber OM, Lipton L, Crabtree M, et al: Multiple colorectal adenomas,
classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348(9):791-799
2. Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, et al: MYH mutations in patients with
attenuated and classic polyposis and with young-onset colorectal cancer without polyps.
Gastroenterology 2004;127(1):9-16 3. Croitoru M, Cleary S, Di Nicola N, et al: Association between
biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst
2004;96:1631-1634
Myocardial Antibodies, Serum
Clinical Information: Myocardial antibodies occur in the sera of patients who have acute
rheumatic fever and carditis, or who have sustained mechanical (surgical or traumatic) or ischemic
damage to myocardial tissue in the postcardiotomy and post myocardial infarction syndromes. In the
"myocardial injury" syndromes, circulating myocardial antibodies become detectable 2 to 3 weeks after
the injury in 30% (infarction) to 70% (postsurgical) of cases and remain detectable for 3 to 8 weeks.
Myocardial antibodies have been detected in some patients with idiopathic cardiomyopathy. The
pathogenic significance of myocardial antibodies is not known.
Useful For: Evaluating patients suspected of having post cardiotomy or post myocardial infarction
syndromes Evaluating patients suspected of having inflammatory cardiomyopathy
Interpretation: Elevated in 30% of myocardial injury patients by the 2nd or 3rd week
Reference Values:
Negative
If positive, results are titered.
Reference values apply to all ages.
Clinical References: Twomey SL, Bernett GE: Immunofluorescence method for detecting
anti-myocardial antibodies, and its use in diagnosing heart disease. Clin Chem 1975;21:1903-1906
Myocarditis/Pericarditis Panel
Reference Values:
MYOCARDITIS-PERICARDITIS PANEL
COXSACKIE B(1-6) ANTIBODIES, SERUM
REFERENCE RANGE: or = 1:32 are indicative of recent infection. Titers of 1:8 or 1:16 may be indicative of
either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or
greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is
considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with
the infecting serotype.
This test was developed and its performance characteristics have been determined by Focus
Diagnostics. Performance characteristics refer to the analytical performance of the test.
ECHOVIRUS ANTIBODIES, SERUM
Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1281